Literature DB >> 20456671

Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life?

John Primrose1, Tom Treasure, Francesca Fiorentino.   

Abstract

The commonest context in which pulmonary metastasectomy is performed is for recurrent colorectal cancer. With a more active policy of surveillance among cancer teams, ready access to ever faster CT scans and a willingness to perform further surgery to control recurrent cancer, the practice of pulmonary metastasectomy is increasing. In this pro/con debate the issues are explored. It is recognized by both sides that there is no randomized trial evidence on which to base the practice. The difference of opinion is whether there is sufficient evidence from very many case series of both pulmonary and hepatic metastasectomy on which to base current practice. The surgeon's view is that the weight of evidence from many follow-up studies is in favour of continuing this practice. The mathematician's view is that case selection could account for nearly all the observed results.

Entities:  

Mesh:

Year:  2010        PMID: 20456671     DOI: 10.1111/j.1440-1843.2010.01759.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  11 in total

Review 1.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes.

Authors:  Michael J Hayes; Victoria Kaestner; Sham Mailankody; Vinay Prasad
Journal:  CMAJ Open       Date:  2018-01-15

Review 3.  Systemic Versus Local Therapies for Colorectal Cancer Pulmonary Metastasis: What to Choose and When?

Authors:  Tony Ibrahim; Lambros Tselikas; Charbel Yazbeck; Joseph Kattan
Journal:  J Gastrointest Cancer       Date:  2016-09

Review 4.  Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?

Authors:  Hong Kwan Kim; Jong Ho Cho; Ho Yun Lee; Jeeyun Lee; Jhingook Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Authors:  David A Palma; Cornelis J A Haasbeek; George B Rodrigues; Max Dahele; Michael Lock; Brian Yaremko; Robert Olson; Mitchell Liu; Jason Panarotto; Gwendolyn H M J Griffioen; Stewart Gaede; Ben Slotman; Suresh Senan
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

6.  Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

Authors:  Iva Kirac; Mario Sekerija; Iva Simunović; Lina Zgaga; Danko Velimir Vrdoljak; Dujo Kovacević; Tomislav Kulis; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

7.  Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis.

Authors:  Seok Kim; Hong Kwan Kim; Jong Ho Cho; Yong Soo Choi; Kwhanmien Kim; Jhingook Kim; Jae Ill Zo; Young Mog Shim; Jin Seok Heo; Woo Yong Lee; Hee Cheol Kim
Journal:  World J Surg Oncol       Date:  2016-07-29       Impact factor: 2.754

8.  Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Rohann J M Correa; Famke Schneiders; Cornelis J A Haasbeek; George B Rodrigues; Michael Lock; Brian P Yaremko; Glenn S Bauman; Belal Ahmad; Devin Schellenberg; Mitchell Liu; Stewart Gaede; Joanna Laba; Liam Mulroy; Sashendra Senthi; Alexander V Louie; Anand Swaminath; Anthony Chalmers; Andrew Warner; Ben J Slotman; Tanja D de Gruijl; Alison Allan; Suresh Senan
Journal:  BMC Cancer       Date:  2019-08-19       Impact factor: 4.430

9.  Thoracic surgical management of colorectal lung metastases: a questionnaire survey of members of the Society for Cardiothoracic Surgery in Great Britain and Ireland.

Authors:  S Jegatheeswaran; T Satyadas; A J Sheen; T Treasure; A K Siriwardena
Journal:  Ann R Coll Surg Engl       Date:  2013-03       Impact factor: 1.891

10.  Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.

Authors:  Robert Olson; Mitchell Liu; Alanah Bergman; Sonya Lam; Fred Hsu; Benjamin Mou; Tanya Berrang; Ante Mestrovic; Nick Chng; Derek Hyde; Quinn Matthews; Chad Lund; Daniel Glick; Howard Pai; Parminder Basran; Hannah Carolan; Boris Valev; Shilo Lefresene; Scott Tyldesley; Devin Schellenberg
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.